Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Rani Therapeutics Holdings, Inc.RANI · Entity 6642 | Director | May 28, 2026 | June 01, 2026 |
| TAKEDA PHARMACEUTICAL CO LTDTAK · Entity 2662 | Director | March 18, 2026 | March 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Rani Therapeutics Holdings, Inc.
Report date May 28, 2026 · Filed June 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Director Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.95 · Expires 2036-05-27 | Direct | 123,600 |
Reported balance
After 2026-05-28 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-28 · Grant · Acquired 123,600 · Balance 123,600 F1: The shares subject to the option vest in full on the first anniversary of the date of grant, subject to the Reporting Person's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan (the "2021 Plan")) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Company's next annual stockholder meeting or a Change in Control (as defined in the 2021 Plan), each subject to the Reporting Person's Continuous Service through such date. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares subject to the option vest in full on the first anniversary of the date of grant, subject to the Reporting Person's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan (the "2021 Plan")) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Company's next annual stockholder meeting or a Change in Control (as defined in the 2021 Plan), each subject to the Reporting Person's Continuous Service through such date.
TAKEDA PHARMACEUTICAL CO LTD
Report date March 18, 2026 · Filed March 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| American Depositary SharesSEC Table I · non-derivative | Direct | 7,600 |
Reported balance
Holding disclosure · report date 2026-03-18 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 7,600 |
| Ordinary SharesSEC Table I · non-derivative | Direct | 9,700 |
Reported balance
Holding disclosure · report date 2026-03-18 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 9,700 F1: Represents an award of restricted stock units (RSU). Each RSU represents a contingent right to receive one Ordinary Share, which will be converted into an equivalent number of American Depositary Shares following vest. The RSUs vest on the following schedule: June 1, 2026 (3,100 ordinary shares), June 1, 2027 (3,400 ordinary shares) and June 1, 2028 (3,200 ordinary shares). |
| Tax Obligation AwardSEC Table II · derivative / convertible security · Expires 2026-06-01 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-03-18 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance Not disclosed F2: Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares. |
| Tax Obligation AwardSEC Table II · derivative / convertible security · Expires 2027-06-01 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-03-18 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance Not disclosed F2: Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares. |
| Tax Obligation AwardSEC Table II · derivative / convertible security · Expires 2028-06-01 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-03-18 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance Not disclosed F2: Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares. |
| Cash Settled Retirement AwardSEC Table II · derivative / convertible security | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-03-18 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance Not disclosed F3: Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive a cash amount equivalent to the value of one Ordinary Share at the time of vest. The RSUs vest upon the director's retirement from the board. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of restricted stock units (RSU). Each RSU represents a contingent right to receive one Ordinary Share, which will be converted into an equivalent number of American Depositary Shares following vest. The RSUs vest on the following schedule: June 1, 2026 (3,100 ordinary shares), June 1, 2027 (3,400 ordinary shares) and June 1, 2028 (3,200 ordinary shares).
F2: Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares.
F3: Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive a cash amount equivalent to the value of one Ordinary Share at the time of vest. The RSUs vest upon the director's retirement from the board.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
VARIAN MEDICAL SYSTEMS INC
Report date April 15, 2021 · Filed April 16, 2021
Section 16 reporting ended · disclosed 2021-04-16. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 1
1 source rowRow 1 · 2021-04-15 · Disposition to issuer · Disposed 4,048 · Balance 0 F1: Disposed of pursuant to merger agreement (the "Merger Agreement") between issuer and Siemens Healthineers I GmbH and certain other parties in exchange for a cash payment of $177.50 per share of common stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-04-15 · Disposition to issuer · Disposed 1,022 · Balance 0 F2: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F3: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting on the earlier of February 15, 2022, or the next Annual Meeting of Stockholders that occurs after the Grant Date, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to merger agreement (the "Merger Agreement") between issuer and Siemens Healthineers I GmbH and certain other parties in exchange for a cash payment of $177.50 per share of common stock.
F2: Each restricted stock unit represents a contingent right to receive one share of VAR common stock.
F3: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting on the earlier of February 15, 2022, or the next Annual Meeting of Stockholders that occurs after the Grant Date, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 28, 2026 Filed Jun 1, 2026 20:09 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | GrantDirector Stock Option (Right to Buy) · Derivative | 123,600 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0001260801-26-000007 · ownership.xml · derivative · entry 1 BUTEL JEAN LUC · CIK 0001260801 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,600 Underlying: Class A Common Stock · 123,600 shares Expires 2036-05-27 F1 · derivative.exercise_date: The shares subject to the option vest in full on the first anniversary of the date of grant, subject to the Reporting Person's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan (the "2021 Plan")) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Company's next annual stockholder meeting or a Change in Control (as defined in the 2021 Plan), each subject to the Reporting Person's Continuous Service through such date. Read SEC document |
| May 28, 2025 Filed May 30, 2025 21:52 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | GrantDirector Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $0.62 | $0.00 |
DisclosureSEC source: 0001415889-25-015035 · form4-05302025_090531.xml · derivative · entry 1 BUTEL JEAN LUC · CIK 0001260801 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Class A Common Stock · 50,000 shares Expires 2035-05-27 F1 · derivative.exercise_date: The shares subject to the option vest in full on the first anniversary of the date of grant, subject to the recipient's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Company's next annual stockholder meeting or a Change in Control (as defined in the Company's 2021 Equity Incentive Plan). Read SEC document |
| December 16, 2024 Filed Dec 17, 2024 22:00 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | GrantStock Option (Right to Buy) · Derivative | 18,875 | Not disclosed Strike: $9.44 | Not disclosed |
DisclosureSEC source: 0000950170-24-137323 · ownership.xml · derivative · entry 4 BUTEL JEAN LUC · CIK 0001260801 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,896 Underlying: Class A Common Stock · 18,875 shares Expires 2031-07-28 F3 · price: On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $9.44 per share. There is no change to the expiration dates or the vesting schedule of the options. F2 · derivative.exercise_date: The shares subject to the option vested as follows: 1/3rd of the shares subject to the option vested on April 20, 2022; and 1/36th of the shares subject to the option vested monthly over the following two years. Read SEC document |
| December 16, 2024 Filed Dec 17, 2024 22:00 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | Disposition to issuerStock Option (Right to Buy) · Derivative | 18,875 | Not disclosed Strike: $2.84 | Not disclosed |
DisclosureSEC source: 0000950170-24-137323 · ownership.xml · derivative · entry 3 BUTEL JEAN LUC · CIK 0001260801 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 18,875 shares Expires 2031-07-28 F3 · price: On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $9.44 per share. There is no change to the expiration dates or the vesting schedule of the options. F2 · derivative.exercise_date: The shares subject to the option vested as follows: 1/3rd of the shares subject to the option vested on April 20, 2022; and 1/36th of the shares subject to the option vested monthly over the following two years. Read SEC document |
| December 16, 2024 Filed Dec 17, 2024 22:00 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | GrantStock Option (Right to Buy) · Derivative | 101,276 | Not disclosed Strike: $4.11 | Not disclosed |
DisclosureSEC source: 0000950170-24-137323 · ownership.xml · derivative · entry 2 BUTEL JEAN LUC · CIK 0001260801 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,276 Underlying: Class A Common Stock · 101,276 shares Expires 2033-05-24 F1 · price: On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $4.11 per share. There is no change to the expiration dates or the vesting schedule of the options. Read SEC document |
| December 16, 2024 Filed Dec 17, 2024 22:00 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | Disposition to issuerStock Option (Right to Buy) · Derivative | 101,276 | Not disclosed Strike: $2.84 | Not disclosed |
DisclosureSEC source: 0000950170-24-137323 · ownership.xml · derivative · entry 1 BUTEL JEAN LUC · CIK 0001260801 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 101,276 shares Expires 2033-05-24 F1 · price: On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $4.11 per share. There is no change to the expiration dates or the vesting schedule of the options. Read SEC document |
| May 29, 2024 Filed May 30, 2024 20:10 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0000950170-24-066578 · ownership.xml · derivative · entry 1 BUTEL JEAN LUC · CIK 0001260801 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Class A Common Stock · 50,000 shares Expires 2034-05-28 F1 · derivative.exercise_date: The shares subject to the option vest in full on the first anniversary of the date of grant, subject to the recipient's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Company's next annual stockholder meeting or a Change in Control (as defined in the Company's 2021 Equity Incentive Plan). Read SEC document |
| December 16, 2023 Filed Dec 19, 2023 21:05 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | GrantStock Option (Right to Buy) · Derivative | 18,875 | Not disclosed Strike: $2.84 | Not disclosed |
DisclosureSEC source: 0000950170-23-071469 · ownership.xml · derivative · entry 4 BUTEL JEAN LUC · CIK 0001260801 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,875 Underlying: Class A Common Stock · 18,875 shares Expires 2031-07-28 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options. F4 · derivative.exercise_date: The shares subject to the option vest as follows: 1/3rd of the shares subject to the option vest on April 20, 2022; and 1/36th of the shares subject to the option vest monthly over the following two years. Read SEC document |
| December 16, 2023 Filed Dec 19, 2023 21:05 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | Disposition to issuerStock Option (Right to Buy) · Derivative | 18,875 | Not disclosed Strike: $9.44 | Not disclosed |
DisclosureSEC source: 0000950170-23-071469 · ownership.xml · derivative · entry 3 BUTEL JEAN LUC · CIK 0001260801 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,021 Underlying: Class A Common Stock · 18,875 shares Expires 2031-07-28 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options. F3 · derivative.exercise_date: The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date. F4 · derivative.exercise_date: The shares subject to the option vest as follows: 1/3rd of the shares subject to the option vest on April 20, 2022; and 1/36th of the shares subject to the option vest monthly over the following two years. F3 · balance_after: The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date. Read SEC document |
| December 16, 2023 Filed Dec 19, 2023 21:05 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | GrantStock Option (Right to Buy) · Derivative | 101,276 | Not disclosed Strike: $2.84 | Not disclosed |
DisclosureSEC source: 0000950170-23-071469 · ownership.xml · derivative · entry 2 BUTEL JEAN LUC · CIK 0001260801 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,276 Underlying: Class A Common Stock · 101,276 shares Expires 2033-05-24 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options. F1 · derivative.exercise_date: The shares subject to the option vest in full on May 25, 2024, subject to the recipient's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Issuer's next annual stockholder meeting or a Change in Control (as defined in the 2021 Equity Incentive Plan). Read SEC document |
| December 16, 2023 Filed Dec 19, 2023 21:05 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | Disposition to issuerStock Option (Right to Buy) · Derivative | 101,276 | Not disclosed Strike: $4.11 | Not disclosed |
DisclosureSEC source: 0000950170-23-071469 · ownership.xml · derivative · entry 1 BUTEL JEAN LUC · CIK 0001260801 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 101,276 shares Expires 2033-05-24 F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options. F1 · derivative.exercise_date: The shares subject to the option vest in full on May 25, 2024, subject to the recipient's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Issuer's next annual stockholder meeting or a Change in Control (as defined in the 2021 Equity Incentive Plan). Read SEC document |
| November 17, 2023 Filed Nov 21, 2023 21:05 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 50,500 | $2.03 | $102,494.80 |
DisclosureSEC source: 0000950170-23-065474 · ownership.xml · nonDerivative · entry 1 BUTEL JEAN LUC · CIK 0001260801 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,500 Read SEC document |
| May 25, 2023 Filed May 31, 2023 00:05 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | GrantStock Option (Right to Buy) · Derivative | 101,276 | $0.00 Strike: $4.11 | $0.00 |
DisclosureSEC source: 0001209191-23-033044 · doc4.xml · derivative · entry 1 BUTEL JEAN LUC · CIK 0001260801 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,276 Underlying: Class A Common Stock · 101,276 shares Expires 2033-05-24 F1 · derivative.exercise_date: The shares subject to the option vest in full on the first anniversary of the date of grant, subject to the recipient's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan) through such vesting date; provided, that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Company's next annual stockholder meeting or a Change in Control (as defined in the 2021 Equity Incentive Plan). Read SEC document |
| May 25, 2022 Filed May 27, 2022 12:30 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | GrantStock Option (Right to Buy) · Derivative | 41,416 | $0.00 Strike: $10.89 | $0.00 |
DisclosureSEC source: 0000899243-22-019857 · doc4.xml · derivative · entry 1 BUTEL JEAN LUC · CIK 0001260801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,416 Underlying: Class A Common Stock · 41,416 shares Expires 2032-05-24 F1 · derivative.exercise_date: The shares subject to the option vest in full on the first anniversary of the date of grant, subject to the recipient's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan) through such vesting date; provided, that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Company's next annual stockholder meeting or a Change in Control (as defined in the 2021 Equity Incentive Plan). Read SEC document |
| April 15, 2021 Filed Apr 16, 2021 20:05 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Disposition to issuerRestricted Stock Units · Derivative | 1,022 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-013932 · form4.xml · derivative · entry 2 BUTEL JEAN LUC · CIK 0001260801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,022 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F3 · price: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting on the earlier of February 15, 2022, or the next Annual Meeting of Stockholders that occurs after the Grant Date, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock. F3 · derivative.exercise_date: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting on the earlier of February 15, 2022, or the next Annual Meeting of Stockholders that occurs after the Grant Date, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock. F3 · derivative.expiration_date: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting on the earlier of February 15, 2022, or the next Annual Meeting of Stockholders that occurs after the Grant Date, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock. Read SEC document |
| April 15, 2021 Filed Apr 16, 2021 20:05 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Disposition to issuerCommon Stock | 4,048 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-013932 · form4.xml · nonDerivative · entry 1 BUTEL JEAN LUC · CIK 0001260801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Disposed of pursuant to merger agreement (the "Merger Agreement") between issuer and Siemens Healthineers I GmbH and certain other parties in exchange for a cash payment of $177.50 per share of common stock. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 19:13 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionRestricted Stock Units · Derivative | 1,225 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-006383 · form4.xml · derivative · entry 3 BUTEL JEAN LUC · CIK 0001260801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,225 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F3 · derivative.exercise_date: The restricted stock units vest on the earlier of February 14, 2021, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date. F3 · derivative.expiration_date: The restricted stock units vest on the earlier of February 14, 2021, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 19:13 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Tax withholdingCommon Stock | 367 | $176.15 | $64,647.05 |
DisclosureSEC source: 0001127602-21-006383 · form4.xml · nonDerivative · entry 2 BUTEL JEAN LUC · CIK 0001260801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,048 F2 · shares: Represents shares withheld from settlement of restricted stock units for the payment of federal taxes due on settlement. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 19:13 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 1,225 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-006383 · form4.xml · nonDerivative · entry 1 BUTEL JEAN LUC · CIK 0001260801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,415 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 08:52 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GrantRestricted Stock Units · Derivative | 1,022 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005612 · form4.xml · derivative · entry 1 BUTEL JEAN LUC · CIK 0001260801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,022 Underlying: Common Stock · 1,022 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F2 · derivative.exercise_date: The restricted stock units vest on the earlier of February 15, 2022, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date. F2 · derivative.expiration_date: The restricted stock units vest on the earlier of February 15, 2022, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 20:43 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionDeferred Stock Units · Derivative | 1,871 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-009518 · form4.xml · derivative · entry 3 BUTEL JEAN LUC · CIK 0001260801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,871 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of VAR stock. F1 · price: Each deferred stock unit represents the right to receive one share of VAR stock. F3 · derivative.exercise_date: The Deferred Stock Units vest in four equal quarterly installments over a 12 month period beginning March 1, 2017. Vested shares will be delivered to the reporting person on the earlier of three years from the grant date, termination/retirement date, or a change in control. F4 · derivative.expiration_date: The Deferred Stock Units vest in four equal quarterly installments over a 12 month period beginning March 1, 2017. Vested shares will be delivered to the reporting person on the earlier of three years from the grant date, termination/retirement date, or a change in control. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 20:43 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Tax withholdingCommon Stock | 561 | $126.55 | $70,994.55 |
DisclosureSEC source: 0001127602-20-009518 · form4.xml · nonDerivative · entry 2 BUTEL JEAN LUC · CIK 0001260801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,190 F2 · kind: Represents shares withheld from settlement of deferred stock units for the payment of federal taxes due on settlement. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 20:43 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 1,871 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-009518 · form4.xml · nonDerivative · entry 1 BUTEL JEAN LUC · CIK 0001260801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,751 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each deferred stock unit represents the right to receive one share of VAR stock. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 19:08 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GrantRestricted Stock Units · Derivative | 1,225 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-006578 · form4.xml · derivative · entry 1 BUTEL JEAN LUC · CIK 0001260801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,225 Underlying: Common Stock · 1,225 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F2 · derivative.exercise_date: The restricted stock units vest on the earlier of February 14, 2021, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date. F2 · derivative.expiration_date: The restricted stock units vest on the earlier of February 14, 2021, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 19:28 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionRestricted Stock Units · Derivative | 1,243 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-006192 · form4.xml · derivative · entry 3 BUTEL JEAN LUC · CIK 0001260801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,243 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F3 · derivative.exercise_date: The restricted stock units vest on the earlier of February 15, 2020, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date. F3 · derivative.expiration_date: The restricted stock units vest on the earlier of February 15, 2020, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 19:28 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Tax withholdingCommon Stock | 372 | $146.91 | $54,650.52 |
DisclosureSEC source: 0001127602-20-006192 · form4.xml · nonDerivative · entry 2 BUTEL JEAN LUC · CIK 0001260801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,880 F1 · kind: Represents shares withheld from settlement of restricted stock units for the payment of federal taxes due on settlement. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 19:28 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 1,243 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-006192 · form4.xml · nonDerivative · entry 1 BUTEL JEAN LUC · CIK 0001260801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,252 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 18:44 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GrantRestricted Stock Units · Derivative | 1,243 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-007292 · form4.xml · derivative · entry 1 BUTEL JEAN LUC · CIK 0001260801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,243 Underlying: Common Stock · 1,243 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F2 · derivative.exercise_date: The restricted stock units vest on the earlier of February 15, 2020, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date. F2 · derivative.expiration_date: The restricted stock units vest on the earlier of February 15, 2020, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| February 11, 2019 Filed Feb 14, 2019 20:34 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionRestricted Stock Units · Derivative | 1,441 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006150 · form4.xml · derivative · entry 3 BUTEL JEAN LUC · CIK 0001260801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,441 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F3 · derivative.exercise_date: The restricted stock units vest on the earlier of February 9, 2019, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date. F3 · derivative.expiration_date: The restricted stock units vest on the earlier of February 9, 2019, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| February 11, 2019 Filed Feb 14, 2019 20:34 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Tax withholdingCommon Stock | 432 | $131.09 | $56,630.88 |
DisclosureSEC source: 0001127602-19-006150 · form4.xml · nonDerivative · entry 2 BUTEL JEAN LUC · CIK 0001260801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,009 F1 · kind: Represents shares withheld from settlement of restricted stock units for the payment of federal taxes due on settlement. Read SEC document |
| February 11, 2019 Filed Feb 14, 2019 20:34 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 1,441 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006150 · form4.xml · nonDerivative · entry 1 BUTEL JEAN LUC · CIK 0001260801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,441 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2018 Filed Feb 12, 2018 20:19 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GrantRestricted Stock Units · Derivative | 1,441 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-005274 · form4.xml · derivative · entry 1 BUTEL JEAN LUC · CIK 0001260801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,441 Underlying: Common Stock · 1,441 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F2 · derivative.exercise_date: The restricted stock units vest on the earlier of February 9, 2019, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date. F2 · derivative.expiration_date: The restricted stock units vest on the earlier of February 9, 2019, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 20:00 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GrantDeferred Stock Units · Derivative | 1,871 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-009893 · form4.xml · derivative · entry 1 BUTEL JEAN LUC · CIK 0001260801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,871 Underlying: Common Stock · 1,871 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit represents the right to receive one share of VAR common stock. F2 · derivative.exercise_date: The Deferred Stock Units vest in four equal quarterly installments over a 12 month period beginning March 1, 2017. Vested shares will be delivered to the reporting person on the earlier of three years from the grant date, termination/retirement date, or a change of control. F2 · derivative.expiration_date: The Deferred Stock Units vest in four equal quarterly installments over a 12 month period beginning March 1, 2017. Vested shares will be delivered to the reporting person on the earlier of three years from the grant date, termination/retirement date, or a change of control. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.